Skip to main content
UniHealth

Doctor search

David Philip Bissig, MD

Neurology · Sacramento

NPI 1144648338

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
12 years
Wayne State University School of Medicine, 2014

Offices

2 locations · Regents of the University of California · Regents of the Univ of CA

Looking this up.

Hospitals listed: University of California Davis Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bissig’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A140344 · Current

Licensed to practise in California · since 2016 · expires 2027-12-31 · Wayne State University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Psychiatry and Neurology - Neurology

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • University of California Davis Medical CenterSacramento, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UC Davis Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 1.94 (1.18 to 2.71) · 3,010 cases, Jul 2022 – Jun 2024Worse than the national rate — MRSA Bacteremia: 1.564, Oct 2024 – Sep 2025Worse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.7 (5.6 to 8) · 1,134 cases, Jan 2024 – Dec 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (10.9 to 14.5) · 1,134 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 127.46 (95.81 to 159.1) · 281 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.18 (0 to 0.57) · 12,625 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.677, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.713, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,436 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for University of California Davis Medical Center

Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 1 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at University of California Davis Medical Center
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.94 (1.18 to 2.71) · 3,010 casesWorseJul 2022 – Jun 2024
MRSA BacteremiaInfections1.564WorseOct 2024 – Sep 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.7 (5.6 to 8) · 1,134 casesWorseJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.6 (10.9 to 14.5) · 1,134 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths127.46 (95.81 to 159.1) · 281 casesBetterJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.18 (0 to 0.57) · 12,625 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.677BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.713BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,436 casesBetterJan 2024 – Dec 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.98 (0.78 to 1.19)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.2 · 82 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.2 · 165 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.2 · 115 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.7 · 662 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.1 · 463 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 406 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 4,328 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.05 to 0.39) · 13,828 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.3 (0.13 to 0.46) · 14,152 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.29 (2.92 to 5.66) · 4,920 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.78 (0.46 to 3.09) · 2,250 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.07 (1.06 to 3.09) · 4,696 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.46 (5.18 to 13.75) · 2,102 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.35 (3.74 to 8.96) · 2,191 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.48 (1.19 to 3.77) · 1,169 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.3 · 127 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.826No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.899No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.669No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.2 · 131 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.2 · 751 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-25.8 · 127 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits24.1 · 758 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits23.6 · 477 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.6 · 469 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 140 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 65 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits18.3 · 203 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.8 (9.4 to 14.9) · 2,643 casesNo differentJan 2022 – Dec 2024

What patients said (2,768 patients answered, 18% of those asked)

Patient survey stars by topic at University of California Davis Medical Center
Cleanliness2
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness1
Recommend hospital4
Share of patients giving the best answer at University of California Davis Medical Center
Room was "always" clean61%
Nurses "always" communicated well76%
Doctors "always" communicated well78%
Staff "always" explained60%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)68%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night37%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects47%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$44,751

Medicare paid this office $44,751 for 300 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)131$19,290$130
Return visit (30+ min)95$8,689$85
New patient visit (60+ min)32$5,101$159
New patient visit (45+ min)18$1,972$110
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or44$1,564$26
See all 10 services
Every Original Medicare service billed
Long return visit (40+ min)131$19,290$130
Return visit (30+ min)95$8,689$85
New patient visit (60+ min)32$5,101$159
New patient visit (45+ min)18$1,972$110
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or44$1,564$26
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's90$1,208$13
Short return visit (20+ min)19$1,187$59
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes11$1,146$64
Influenza vaccine split virus, preservative free13$1,054$81
Administration of influenza virus vaccine14$478$34

Who their Medicare patients are

300 Original Medicare patients in 2024. Average age 76 · Under 65 8% · 85 and older 15% · Women 53% · Also on Medicaid 20% · Health risk score 1.57. At or below the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 66% · Dementia 61% · Depression 40% · Diabetes 26% · Coronary heart disease 26% · Chronic kidney disease 23% · Atrial fibrillation 20% · Stroke 19% · Heart failure 15% · COPD 14% · Cancer 13%.

The office billed $236,773, Medicare allowed $63,191 and paid $44,751; for 569 services of 29 kinds; $1,076 of it was for drugs given in the office and $43,675 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024300569761.57$236,773$44,751
2023373553761.62$281,551$51,441
20226381,068761.46$566,102$117,912
2021509883761.55$433,336$99,459
2020145179741.85$84,898$16,398
20195090741.34$23,233$6,953
20182035740.81$5,784$3,289

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Long return visit (40+ min)148$22,445$132
Return visit (30+ min)133$11,114$78
New patient visit (60+ min)32$4,899$153
New patient visit (45+ min)28$3,081$110
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or39$1,643$27
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes13$1,383$66
Short return visit (20+ min)16$1,017$64

2022: 14 services

Original Medicare services billed in 2022
Long return visit (40+ min)264$42,368$144
New patient visit (60+ min)194$33,159$171
Return visit (30+ min)179$19,891$99
New patient visit (45+ min)28$3,390$121
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or94$3,047$27
Evaluation of neuropsychological test, first hour22$2,239$102
Exam of neurobehavioral status, first hour31$1,748$56
Extended patient service without direct patient contact, first hour16$1,536$90
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes16$1,168$58
Short return visit (20+ min)17$1,026$57
Influenza vaccine split virus, preservative free15$1,008$67
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes12$982$82
Administration of influenza virus vaccine17$539$32
Administration of psychological or neuropsychological test, first 30 minutes12$317$26

2021: 13 services

Original Medicare services billed in 2021
New patient visit (60+ min)220$39,055$178
Long return visit (40+ min)163$28,875$145
Long return visit (40+ min)44$5,498$115
Return visit (30+ min)32$2,941$92
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or65$2,549$27
New patient visit (60+ min)14$1,915$137
New patient visit (45+ min)17$1,787$105
Evaluation of neuropsychological test, first hour14$1,572$112
Influenza vaccine split virus, preservative free21$1,370$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,358$113
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes15$1,254$84
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or37$1,066$26
Administration of influenza virus vaccine21$384$18

2020: 6 services

Original Medicare services billed in 2020
Long return visit (40+ min)46$4,002$87
New patient visit (60+ min)25$3,126$125
Long return visit (40+ min)20$1,863$93
New patient visit (45+ min)13$1,394$107
Extended office or other outpatient service, first hour15$1,262$84
Return visit (30+ min)11$461$42

2019: 2 services

Original Medicare services billed in 2019
Long return visit (40+ min)12$940$78
Return visit (30+ min)11$635$58

2018: 1 service

Original Medicare services billed in 2018
Extended office or other outpatient service, first hour12$941$78

Drugs they prescribed that Part D paid

$64,329

Pharmacies billed $64,329 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,015) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.

985 generic and 30 brand-name prescriptions · $64,329 in drug cost · 46 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Rivastigmine23$5,896$256
Memantine107$5,768$54
Donepezil361$5,436$15
Doxepin27$4,087$151
Galantamine Hbr47$3,623$77
See all 20 drugs
Every Part D drug this clinician prescribed
Rivastigmine23$5,896$256
Memantine107$5,768$54
Donepezil361$5,436$15
Doxepin27$4,087$151
Galantamine Hbr47$3,623$77
Carbidopa-Levodopa Er15$2,936$196
Carbidopa-Levodopa38$1,324$35
Trazodone57$875$15
Rivastigmine11$843$77
Quetiapine23$714$31
Mirtazapine31$681$22
Escitalopram30$597$20
Sertraline52$474$9
Lamotrigine18$469$26
Duloxetine11$320$29
Gabapentin16$227$14
Dextroamphetamine-Amphetamine11$196$18
Risperidone17$171$10
Citalopram Hbr11$106$10
Fluoxetine11$96$9

Year by year

Part D prescribing by year
20241,0152300% (0)3%$64,329
20231,5402990% (0)3%$105,220
20221,8173470% (0)3%$216,044
20218822080% (0)2%$32,537
2020280710% (0)None$10,800
2019306580% (0)8%$19,453
2018392690% (0)None$136,499
2017388540% (0)16%$76,134
201617726None12%$12,865
201521NoneNoneNone$2,098
201416None0% (0)None$532

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 19 drugs

Part D drugs prescribed in 2023
Rivastigmine55$16,165$294
Donepezil529$11,265$21
Memantine216$10,810$50
Doxepin27$7,426$275
Galantamine Hbr65$5,711$88
Carbidopa-Levodopa85$5,172$61
Memantine Hcl Er13$4,771$367
Carbidopa-Levodopa Er12$4,075$340
Rivastigmine24$2,162$90
Mirtazapine48$1,645$34
Venlafaxine Hcl Er12$1,554$129
Trazodone89$1,357$15
Gabapentin34$1,234$36
Sertraline82$914$11
Quetiapine34$896$26
Levetiracetam14$693$49
Bupropion Xl13$210$16
Risperidone21$200$10
Escitalopram15$191$13

2022: 19 drugs

Part D drugs prescribed in 2022
Ingrezza12$96,457$8,038
Rivastigmine73$20,756$284
Memantine247$13,058$53
Galantamine Hbr97$11,444$118
Donepezil648$11,148$17
Carbidopa-Levodopa112$6,138$55
Myrbetriq11$5,259$478
Rivastigmine31$2,518$81
Trazodone132$1,846$14
Gabapentin49$1,639$33
Levetiracetam18$1,418$79
Quetiapine62$1,415$23
Mirtazapine32$1,133$35
Bupropion Hcl Sr13$819$63
Sertraline91$792$9
Duloxetine20$583$29
Quetiapine Fumarate Er11$271$25
Olanzapine12$198$16
Bupropion Xl18$160$9

2021: 16 drugs

Part D drugs prescribed in 2021
Myrbetriq15$6,197$413
Memantine84$4,866$58
Donepezil345$4,265$12
Galantamine Hbr49$3,511$72
Carbidopa-Levodopa37$2,230$60
Rivastigmine22$1,605$73
Venlafaxine Hcl Er13$1,469$113
Trazodone66$639$10
Mirtazapine12$558$47
Levetiracetam11$505$46
Sertraline81$413$5
Bupropion Xl13$402$31
Duloxetine13$395$30
Bupropion Hcl Sr17$308$18
Quetiapine18$194$11
Gabapentin12$52$4

2020: 6 drugs

Part D drugs prescribed in 2020
Memantine51$2,013$39
Carbidopa-Levodopa12$991$83
Donepezil81$902$11
Sertraline56$465$8
Gabapentin11$155$14
Mirtazapine11$105$10

2019: 6 drugs

Part D drugs prescribed in 2019
Memantine65$2,130$33
Ondansetron11$1,183$108
Donepezil63$644$10
Carbidopa-Levodopa19$628$33
Sertraline39$259$7
Gabapentin12$113$9

2018: 11 drugs

Part D drugs prescribed in 2018
Copaxone12$74,542$6,212
Carbamazepine Er15$2,815$188
Levetiracetam27$879$33
Memantine13$612$47
Gabapentin35$496$14
Atorvastatin17$351$21
Baclofen20$296$15
Donepezil41$291$7
Carbidopa-Levodopa21$252$12
Lidocaine-Prilocaine13$246$19
Quetiapine15$76$5

2017: 15 drugs

Part D drugs prescribed in 2017
Carbamazepine Er21$3,623$173
Sumatriptan12$909$76
Levocarnitine12$434$36
Levetiracetam13$353$27
Baclofen25$325$13
Cyclobenzaprine13$254$20
Topiramate15$251$17
Carbidopa-Levodopa15$232$15
Atorvastatin11$213$19
Donepezil32$159$5
Propranolol12$145$12
Gabapentin12$119$10
Divalproex24$116$5
Lamotrigine12$77$6
Lorazepam13$25$2

2016: 4 drugs

Part D drugs prescribed in 2016
Carbamazepine Er13$1,449$111
Atorvastatin20$429$21
Donepezil15$78$5
Verapamil Er13$63$5

Professional record

NPI
1144648338
Licence
CA A140344, OR MD186924California A140344: Current · expires 2027-12-31
Trained
Wayne State University School of Medicine, 2014 · 12 years ago
Group
Regents of the University of California · Regents of the Univ of CA
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Neurology (2084N0400X)
Mailing address
3160 Folsom Blvd, Sacramento, CA, 95816
NPI first listed
2014-04-03
NPI last updated
2021-10-26
NPI record certified
2021-10-26

This is when the NPI record was last certified, not a medical board exam.